| Mrs Michelle G Stradley, NURSE PRACTITIONER | |
|
9850 W St Lukes Dr Ste 280, Nampa, ID 83687-7912 | |
| (208) 323-3767 | |
| Not Available |
| Full Name | Mrs Michelle G Stradley |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 19 Years |
| Location | 9850 W St Lukes Dr Ste 280, Nampa, Idaho |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235158270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | N-45468 (Idaho) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | NP-1278A (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic-treasure Valley Llc | 4981878402 | 968 |
News Archive
Recent Accreditation Council for Graduate Medical Education limits aimed to enhance patient safety may compromise the quality of doctors' training, according to a study by Mayo Clinic researchers published in the March issue of Mayo Clinic Proceedings.
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published on March 22 in Molecular Pharmacology. The experimental agent also could prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.
Fort Wayne, Ind., fared the best among the major health care markets, the analysis finds. Meanwhile, a new study of a plan to tie Medicare's payments to the quality of doctors' services suggests many physicians may face penalties.
› Verified 9 days ago
| Entity Name | St Lukes Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790718229 PECOS PAC ID: 1052217478 Enrollment ID: O20031208000899 |
News Archive
Recent Accreditation Council for Graduate Medical Education limits aimed to enhance patient safety may compromise the quality of doctors' training, according to a study by Mayo Clinic researchers published in the March issue of Mayo Clinic Proceedings.
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published on March 22 in Molecular Pharmacology. The experimental agent also could prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.
Fort Wayne, Ind., fared the best among the major health care markets, the analysis finds. Meanwhile, a new study of a plan to tie Medicare's payments to the quality of doctors' services suggests many physicians may face penalties.
› Verified 9 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
Recent Accreditation Council for Graduate Medical Education limits aimed to enhance patient safety may compromise the quality of doctors' training, according to a study by Mayo Clinic researchers published in the March issue of Mayo Clinic Proceedings.
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published on March 22 in Molecular Pharmacology. The experimental agent also could prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.
Fort Wayne, Ind., fared the best among the major health care markets, the analysis finds. Meanwhile, a new study of a plan to tie Medicare's payments to the quality of doctors' services suggests many physicians may face penalties.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Michelle G Stradley, NURSE PRACTITIONER 190 E Bannock St, Boise, ID 83712-6241 Ph: () - | Mrs Michelle G Stradley, NURSE PRACTITIONER 9850 W St Lukes Dr Ste 280, Nampa, ID 83687-7912 Ph: (208) 323-3767 |
News Archive
Recent Accreditation Council for Graduate Medical Education limits aimed to enhance patient safety may compromise the quality of doctors' training, according to a study by Mayo Clinic researchers published in the March issue of Mayo Clinic Proceedings.
Novartis announced today that the US Food and Drug Administration (FDA) approved the inclusion of Treatment-free Remission (TFR) data in the Tasigna® (nilotinib) US product label.
Researchers at the University of Pittsburgh School of Medicine and Arts & Sciences have designed a more effective version of an FDA-approved epilepsy drug with the potential for fewer side effects, according to a study published on March 22 in Molecular Pharmacology. The experimental agent also could prove to be a treatment for tinnitus and other disorders caused by volatile neural signaling.
In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.
Fort Wayne, Ind., fared the best among the major health care markets, the analysis finds. Meanwhile, a new study of a plan to tie Medicare's payments to the quality of doctors' services suggests many physicians may face penalties.
› Verified 9 days ago
Karen L Godard, RNC, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1305 3rd St S, Nampa, ID 83651 Phone: 208-475-5700 Fax: 208-475-5710 | |
Mrs. Carolyn G Barnhart, FNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1375 N Happy Valley Rd, Nampa, ID 83687 Phone: 208-809-2869 Fax: 208-809-2868 | |
Nadezhda Kravchuk, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1150 N Sister Catherine Way, Nampa, ID 83687 Phone: 208-302-7000 Fax: 208-302-7055 | |
Guniz Bas Uzer, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 16111 N Brinson St Ste 110, Nampa, ID 83687 Phone: 208-747-0371 | |
Cara Hollingsworth, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9850 W St Lukes Dr, Nampa, ID 83687 Phone: 907-371-1300 | |
Sydney Brown, DNP-APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 Caldwell Blvd, Nampa, ID 83651 Phone: 208-809-2892 Fax: 208-809-2893 | |
Mrs. Danielle Marie Fowler, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4424 E Flamingo Ave Ste 300, Nampa, ID 83687 Phone: 208-205-1000 |